| 000 | 01545 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250517084943.0 | ||
| 264 | 0 | _c20170130 | |
| 008 | 201701s 0 0 fre d | ||
| 022 | _a1773-0597 | ||
| 024 | 7 |
_a10.1016/j.jfo.2015.10.009 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMaringe, E | |
| 245 | 0 | 0 |
_a[Evaluation of the efficacy of aflibercept's in the treatment of neovascular age-related macular degeneration in treatment-naive and switched patients. Report of 86 cases]. _h[electronic resource] |
| 260 |
_bJournal francais d'ophtalmologie _cMar 2016 |
||
| 300 |
_a255-60 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study | ||
| 650 | 0 | 4 | _aDrug Substitution |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aFrance |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIntravitreal Injections |
| 650 | 0 | 4 |
_aMacular Degeneration _xcomplications |
| 650 | 0 | 4 |
_aRanibizumab _xadministration & dosage |
| 650 | 0 | 4 |
_aReceptors, Vascular Endothelial Growth Factor _xadministration & dosage |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xadministration & dosage |
| 650 | 0 | 4 |
_aRetinal Neovascularization _xcomplications |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVisual Acuity _xdrug effects |
| 700 | 1 | _aLetesson, E | |
| 700 | 1 | _aDuncombe, A | |
| 700 | 1 | _aMuraine, M | |
| 700 | 1 | _aGenevois, O | |
| 773 | 0 |
_tJournal francais d'ophtalmologie _gvol. 39 _gno. 3 _gp. 255-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jfo.2015.10.009 _zAvailable from publisher's website |
| 999 |
_c25844957 _d25844957 |
||